首頁 > 市場調查報告書 > 醫療設備

美容整形

市場調查報告書

商品編碼

1542621

全球肉毒桿菌毒素市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

Global Botulinum Toxin Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 161 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球肉毒桿菌毒素市場需求預計將從 2023 年的 159.9 億美元達到近 390.2 億美元的市場規模，2024-2032 年研究期間複合年成長率為 10.42%。

肉毒桿菌毒素（BTX）是由肉毒桿菌產生的中性毒素。它是一種劇毒物質，會抑制乙醯膽鹼的釋放，乙醯膽鹼是一種可能導致弛緩性麻痺的神經傳導物質。肉毒桿菌毒素的主要用途是在醫學上治療患者的神經性疼痛、慢性偏頭痛、過度疼痛和過度活躍的肌肉運動相關疾病。此外，它還可用於化妝品應用，透過放鬆肌肉來減少臉部皺紋

市場動態

偏頭痛、肌肉痙攣及相關病症的盛行率不斷增加，推動了對肉毒桿菌毒素的需求。對減少住院時間、更快康復和小切口的微創治療的需求不斷成長，也推動了產品需求的上升。人們將焦點轉向增強視覺吸引力，這增加了化妝品應用中對肉毒桿菌的需求。然而，該產品的高成本以及與肉毒桿菌的使用相關的副作用可能會抑制其需求。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球肉毒桿菌毒素市場的各個細分市場進行了包容性評估。肉毒桿菌毒素產業的成長和趨勢為本研究提供了整體方法。

市場區隔

肉毒桿菌毒素市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

依產品類型

A 型（Botox、Dysport、Xeomin、其他）
B型

按申請

治療（慢性偏頭痛、膀胱過動症、頸肌張力失調、痙攣等）
美學（眉間紋、魚尾紋、額頭紋等）

按最終用途

醫院
皮膚科診所
美容中心及醫療水療中心

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲肉毒桿菌毒素市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。肉毒桿菌市場的主要參與者包括Ipsen Group、Allergen Inc.、Medi-Tox Inc.、Merz Pharma、US Worldmeds、Evolus、Galderma、Metabiologics Inc.、蘭州生物製品研究所。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：肉毒桿菌毒素公司的競爭格局

肉毒毒素市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市佔率分析
市場集中度
Ipsen Group

公司概況
公司收入
產品
最新動態

Allergen Inc.

公司概況
公司收入
產品
最新動態

Medy-Tox Inc.

公司概況
公司收入
產品
最新動態

Merz Pharma

公司概況
公司收入
產品
最新動態

US Worldmeds

公司概況
公司收入
產品
最新動態

Evolus

公司概況
公司收入
產品
最新動態

Galderma

公司概況
公司收入
產品
最新動態

Metabiologics Inc.

公司概況
公司收入
產品
最新動態

Lanzhou Institute Of Biological Products

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11210936

The global demand for Botulinum Toxin Market is presumed to reach the market size of nearly USD 39.02 Billion by 2032 from USD 15.99 Billion in 2023 with a CAGR of 10.42% under the study period 2024-2032.

Botulinum toxin (BTX) is the neutrotoxin produced by bacterium Clostridium botulinum. It is a highly poisonous substance that inhibits the release of acetylcholine, a neurotransmitter that may cause flaccid paralysis. The prominent use of botulinum toxin is in medicine to cure the patient from neuropathic pain, chronic migraine, excessive pain, and overactive muscle movement related disorders. In addition, it can be used in cosmetics applications, for reducing facial wrinkles by relaxing the muscles

MARKET DYNAMICS

Increasing prevalence of migraine, muscle spasticity & related conditions is driving the demand for the botulinum toxin. The growing demand of minimally invasive treatments for reducing hospital stays, faster recovery, and small incision is also pushing the product demand higher. The shifting focus towards enhancing visual appeal has increased the demand for botulinum toxin in cosmetic application. However, the high cost of the product with side effects associated with the usage of botulinum toxin may curb its demand.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Botulinum Toxin. The growth and trends of Botulinum Toxin industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Botulinum Toxin market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

Type A (Botox, Dysport, Xeomin, Others)
Type B

By Application

Therapeutic (Chronic Migraine, Overactive Bladder, Cervical Dystonia, Spasticity, Others)
Aesthetic (Glabellar Lines, Crow's Feet, Forehead Lines, Others)

By End-use

Hospitals
Dermatology Clinics
Cosmetic Centers And Medspas

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Botulinum Toxin market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Botulinum Toxin market include Ipsen Group, Allergen Inc., Medy-Tox Inc., Merz Pharma, US Worldmeds, Evolus, Galderma, Metabiologics Inc., Lanzhou Institute Of Biological Products. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. BOTULINUM TOXIN - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-use
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL BOTULINUM TOXIN MARKET ANALYSIS BY PRODUCT TYPE

5.1. Overview By Product Type
5.2. Historical and Forecast Data Analysis By Product Type
5.3. Type A (Botox, Dysport, Xeomin, Others) Historic and Forecast Sales By Regions
5.4. Type B Historic and Forecast Sales By Regions

6. GLOBAL BOTULINUM TOXIN MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Therapeutic (Chronic Migraine, Overactive Bladder, Cervical Dystonia, Spasticity, Others) Historic and Forecast Sales By Regions
6.4. Aesthetic (Glabellar Lines, Crow's Feet, Forehead Lines, Others) Historic and Forecast Sales By Regions

7. GLOBAL BOTULINUM TOXIN MARKET ANALYSIS BY END-USE

7.1. Overview By End-use
7.2. Historical and Forecast Data Analysis By End-use
7.3. Hospitals Historic and Forecast Sales By Regions
7.4. Dermatology Clinics Historic and Forecast Sales By Regions
7.5. Cosmetic Centers And Medspas Historic and Forecast Sales By Regions

8. GLOBAL BOTULINUM TOXIN MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE BOTULINUM TOXIN COMPANIES

9.1. Botulinum Toxin Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF BOTULINUM TOXIN INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Ipsen Group
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Allergen Inc.
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Medy-Tox Inc.
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Merz Pharma
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. US Worldmeds
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Evolus
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Galderma
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Metabiologics Inc.
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Lanzhou Institute Of Biological Products
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

簡介目錄圖表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Product Type (USD MN)
Type A (Botox, Dysport, Xeomin, Others) Market Sales By Geography (USD MN)
Type B Market Sales By Geography (USD MN)
Analysis By Application (USD MN)
Therapeutic (Chronic Migraine, Overactive Bladder, Cervical Dystonia, Spasticity, Others) Market Sales By Geography (USD MN)
Aesthetic (Glabellar Lines, Crow's Feet, Forehead Lines, Others) Market Sales By Geography (USD MN)
Analysis By End-use (USD MN)
Hospitals Market Sales By Geography (USD MN)
Dermatology Clinics Market Sales By Geography (USD MN)
Cosmetic Centers And Medspas Market Sales By Geography (USD MN)
Global Botulinum Toxin Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Botulinum Toxin Report
Market Research Process
Market Research Methodology
Global Botulinum Toxin Market Size, By Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Product Type
Market Attractiveness Analysis By Application
Market Attractiveness Analysis By End-use
Market Attractiveness Analysis By Region
Value Chain Analysis
Global Market Analysis By Product Type (USD MN)
Type A (Botox, Dysport, Xeomin, Others) Market Sales By Geography (USD MN)
Type B Market Sales By Geography (USD MN)
Global Market Analysis By Application (USD MN)
Therapeutic (Chronic Migraine, Overactive Bladder, Cervical Dystonia, Spasticity, Others) Market Sales By Geography (USD MN)
Aesthetic (Glabellar Lines, Crow's Feet, Forehead Lines, Others) Market Sales By Geography (USD MN)
Global Market Analysis By End-use (USD MN)
Hospitals Market Sales By Geography (USD MN)
Dermatology Clinics Market Sales By Geography (USD MN)
Cosmetic Centers And Medspas Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis